Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Goodeve

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2016
Genetic analysis of bleeding disordersE Edison, B A Konkle, A C Goodeve
British Journal of Haematology|September 24, 2004
Activating loop mutations in the PDGFR alpha and beta genes are rare in core binding factor acute myeloid leukaemiaM F Johan, A C Goodeve, J T Reilly
Journal of Thrombosis and Haemostasis : JTH|May 20, 2011
Nomenclature of genetic variants in hemostasisA C Goodeve, P H Reitsma, J H McVey, et al.
Lancet (London, England)|February 5, 1994
Factor VIII gene rearrangements in patients with severe haemophilia AA C Goodeve, F E Preston, I R Peake
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 31, 2008
Type 1 von Willebrand disease: application of emerging data to clinical practiceP W Collins, A M Cumming, A C Goodeve, et al.
Biochemical and Biophysical Research Communications|February 13, 2001
Endoplasmic reticulum retention and prolonged association of a von Willebrand's disease-causing von Willebrand factor variant with ERp57 and calnexinS Allen, A C Goodeve, I R Peake, et al.
Thrombosis and Haemostasis|July 15, 2000
Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study GroupA C Goodeve, I Williams, G L Bray, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2016
In silico analysis highlights the copy number variation mechanism responsible for the historically reported VWF exon 42 deletionA Cartwright, I R Peake, A C Goodeve, et al.
Thrombosis and Haemostasis|November 1, 1996
von Willebrand factor/factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factorI M Nesbitt, A C Goodeve, F E Preston, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1996
A rapid and cost effective method for analysis of dinucleotide repeat polymorphisms in the factor VIII geneA C Goodeve, G Tagariello, A Chuansumrit, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2016
Genetic analysis of bleeding disordersE Edison, B A Konkle, A C Goodeve
British Journal of Haematology|September 24, 2004
Activating loop mutations in the PDGFR alpha and beta genes are rare in core binding factor acute myeloid leukaemiaM F Johan, A C Goodeve, J T Reilly
Journal of Thrombosis and Haemostasis : JTH|May 20, 2011
Nomenclature of genetic variants in hemostasisA C Goodeve, P H Reitsma, J H McVey, et al.
Lancet (London, England)|February 5, 1994
Factor VIII gene rearrangements in patients with severe haemophilia AA C Goodeve, F E Preston, I R Peake
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 31, 2008
Type 1 von Willebrand disease: application of emerging data to clinical practiceP W Collins, A M Cumming, A C Goodeve, et al.
Biochemical and Biophysical Research Communications|February 13, 2001
Endoplasmic reticulum retention and prolonged association of a von Willebrand's disease-causing von Willebrand factor variant with ERp57 and calnexinS Allen, A C Goodeve, I R Peake, et al.
Thrombosis and Haemostasis|July 15, 2000
Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study GroupA C Goodeve, I Williams, G L Bray, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2016
In silico analysis highlights the copy number variation mechanism responsible for the historically reported VWF exon 42 deletionA Cartwright, I R Peake, A C Goodeve, et al.
Thrombosis and Haemostasis|November 1, 1996
von Willebrand factor/factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factorI M Nesbitt, A C Goodeve, F E Preston, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1996
A rapid and cost effective method for analysis of dinucleotide repeat polymorphisms in the factor VIII geneA C Goodeve, G Tagariello, A Chuansumrit, et al.
Pageof 5